COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
References
- WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2022 Nov 29]. Available from:
https://covid19.who.int . - Coronavirus vaccine – summary of Yellow Card reporting [Internet]. GOV.UK. [cited 2022 Dec 12]. Available from:
https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting . - EMA.
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2021 [Internet] . European Medicines Agency. 2021 [cited 2022 Dec 12]. Available from:https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-7-10-june-2021 . - COVID-19 VaST Technical Report June 28, 2021 | CDC [Internet]. 2021 [cited 2022 Dec 12]. Available from:
https://www.cdc.gov/vaccines/acip/work-groups-vast/report-2021-06-28.html . - Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022 Feb; 28(2): 410–22. DOI: 10.1038/s41591-021-01630-0
- Engler RJM, Nelson MR, Collins LC, Spooner C, Hemann BA, Gibbs BT, et al. A prospective study of the incidence of myocarditis/pericarditis and new onset cardiac symptoms following smallpox and influenza vaccination. PloS One. 2015; 10(3):
e0118283 . DOI: 10.1371/journal.pone.0118283 - Vickers M, Ramineni V, Malacova E, Eriksson L, McMahon K, Moudgil V, et al. Risk factors for clozapine-induced myocarditis and cardiomyopathy: A systematic review and meta-analysis. Acta Psychiatr Scand. 2022 May; 145(5): 442–55. DOI: 10.1111/acps.13398
- Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: Clinical observations and potential mechanisms. Nat Rev Cardiol. 2022 Feb; 19(2): 75–7. DOI: 10.1038/s41569-021-00662-w
- Ammirati E, Lupi L, Palazzini M, Hendren NS, Grodin JL, Cannistraci CV, et al. Prevalence, characteristics, and outcomes of COVID-19–Associated Acute Myocarditis. Circulation. 2022 Apr 12; 145(15): 1123–39. DOI: 10.1161/CIRCULATIONAHA.121.056817
- Boehmer TK, Kompaniyets L, Lavery AM, Hsu J, Ko JY, Yusuf H, et al. Association between COVID-19 and myocarditis using hospital-based administrative data— United States, March 2020–January 2021. Morb Mortal Wkly Rep. 2021 Sep 3; 70(35): 1228–32. DOI: 10.15585/mmwr.mm7035e5
- Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Engl J Med. 2021 Aug 25; NEJMoa2110475. DOI: 10.1056/NEJMoa2110475
- Ali M, Shiwani HA, Elfaki MY, Hamid M, Pharithi R, Kamgang R, et al. COVID-19 and myocarditis: A review of literature. Egypt Heart J EHJ Off Bull Egypt Soc Cardiol. 2022 Apr 5; 74(1): 23. DOI: 10.1186/s43044-022-00260-2
- Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014 Oct 28; 130(18): 1601–6. DOI: 10.1161/CIRCULATIONAHA.114.010376
- Lin AH, Phan HAL, Barthel RV, Maisel AS, Crum-Cianflone NF, Maves RC, et al. Myopericarditis and pericarditis in the deployed military member: A retrospective series. Mil Med. 2013 Jan 1; 178(1): 18–20. DOI: 10.7205/MILMED-D-12-00226
- Elfström P, Hamsten A, Montgomery SM, Ekbom A, Ludvigsson JF. Cardiomyopathy, pericarditis and myocarditis in a population-based cohort of inpatients with coeliac disease. J Intern Med. 2007; 262(5): 545–54. DOI: 10.1111/j.1365-2796.2007.01843.x
- Buckley BJR, Harrison SL, Fazio-Eynullayeva E, Underhill P, Lane DA, Lip GYH. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021 Nov; 51(11):
e13679 . DOI: 10.1111/eci.13679 - Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021 Aug 10; 144(6): 471–84. DOI: 10.1161/CIRCULATIONAHA.121.056135
- Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the advisory committee on immunization practices – United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 9; 70(27): 977–82. DOI: 10.15585/mmwr.mm7027e2
- Lane S, Yeomans A, Shakir S. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: A systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature. BMJ Open. 2022 May 25; 12(5):
e059223 . DOI: 10.1136/bmjopen-2021-059223 - Pillay J, Gaudet L, Wingert A, Bialy L, Mackie AS, Paterson DI, et al. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following COVID-19 vaccination: Living evidence syntheses and review. BMJ. 2022 Jul 13; 378:
e069445 . DOI: 10.1136/bmj-2021-069445 - Wong HL, Hu M, Zhou CK, Lloyd PC, Amend KL, Beachler DC, et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: A cohort study in claims databases. Lancet Lond Engl. 2022 Jun 11; 399(10342): 2191–9. DOI: 10.1016/S0140-6736(22)00791-7
- Ahmed SK, Mohamed MG, Essa RA, Ahmed Rashad EA, Ibrahim PK, Khdir AA, et al. Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis. Diabetes Metab Syndr. 2022 Jun; 16(6): 102513. DOI: 10.1016/j.dsx.2022.102513
- Basso C. Myocarditis. N Engl J Med. 2022 Oct 20; 387(16): 1488–500. DOI: 10.1056/NEJMra2114478
- Husby A, Hansen JV, Fosbøl E, Thiesson EM, Madsen M, Thomsen RW, et al. SARS-CoV-2 vaccination and myocarditis or myopericarditis: Population based cohort study. The BMJ. 2021 Dec 16; 375:
e068665 . DOI: 10.1136/bmj-2021-068665 - Ab Rahman N, Lim MT, Lee FY, Anak Jam EB, Peariasamy KM, Sivasampu S. Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia. Vaccine X. 2023 Aug 1; 14: 100303. DOI: 10.1016/j.jvacx.2023.100303
- Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993 Feb 1; 118(3): 201–10. DOI: 10.7326/0003-4819-118-3-199302010-00009
- Karlstad Ø, Hovi P, Husby A, Härkänen T, Selmer RM, Pihlström N, et al. SARS-CoV-2 vaccination and myocarditis in a nordic cohort study of 23 million residents. JAMA Cardiol. 2022 Jun 1; 7(6): 600–12. DOI: 10.1001/jamacardio.2022.0583
- Kracalik I, Oster ME, Broder KR, Cortese MM, Glover M, Shields K, et al. Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: A follow-up surveillance study. Lancet Child Adolesc Health. 2022 Nov 1; 6(11): 788–98. DOI: 10.1016/S2352-4642(22)00244-9
- VAERS | Vaccine Safety | CDC [Internet]. 2022 [cited 2023 Jan 26]. Available from:
https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html . - McMahan B, Moore E, Ramage D, Hampson S, Agüera, y Arcas B. Communication-efficient learning of deep networks from decentralized data. In: Proceedings of the 20th International Conference on Artificial Intelligence and Statistics.
PMLR . 2017; 1273–82. - Li T, Sahu AK, Talwalkar A, Smith V. Federated learning: Challenges, methods, and future directions. IEEE Signal Process Mag. 2020 May; 37(3): 50–60. DOI: 10.1109/MSP.2020.2975749
- Sera F, Armstrong B, Blangiardo M, Gasparrini A. An extended mixed-effects framework for meta-analysis. Stat Med. 2019 Dec 20; 38(29): 5429–44. DOI: 10.1002/sim.8362
DOI: https://doi.org/10.5334/gh.1252 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 11, 2023
Accepted on: Jun 27, 2023
Published on: Jul 31, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Laura C. Zwiers, David S. Y. Ong, Diederick E. Grobbee, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.